Search results
Mark Carter. Group Leader, Stem Cell Biology at Minerva Biotechnologies. Show contact. Mark Carter has a long and varied work history, beginning in 1991 when they were a Clinical Laboratory Technician and Computer Systems Manager at Brigham and Women's Hospital.
Mark G. Carter, PhD. Group Leader, Stem Cell Biology at Minerva Biotechnologies. Linkedin Profile.
- Group Leader, Stem Cell Biology
- Minerva Biotechnologies
Mar 1, 2011 · View Mark Carter’s profile on LinkedIn, a professional community of 1 billion members.
- 155
- 155
- Minerva Biotechnologies
Mark G. Carter's 19 research works with 25 citations and 478 reads, including: Abstract 1148: 1XX mutations slow CAR T cell signaling and increase in vivo persistence.
Mar 7, 2013 · We report that a single growth factor, NM23-H1, enables serial passaging of both human ES and iPS cells in the absence of feeder cells, their conditioned media or bFGF in a fully defined xeno-free media on a novel defined, xeno-free surface.
- Benoit J. Smagghe, Andrew K. Stewart, Mark G. Carter, Laura M. Shelton, Kyle J. Bernier, Eric J. Har...
- 2013
Toshio Hamatani, Mark G. Carter, Alexei A. Sharov, Minoru S.H. Ko. Research output: Contribution to journal › Article › peer-review. 734 Citations (Scopus) Overview. Fingerprint. Abstract.
Mark G Carter's 10 research works with 219 citations and 1,208 reads, including: Jak/Stat3 Signaling Promotes Somatic Cell Reprogramming by Epigenetic Regulation